Canada wants to clear the way for more decentralized clinical trials: Will the US follow suit?

The clinical trial ecosystem in North America was upended quickly by Covid-19, casting a giant spotlight on inefficiencies and the need to make room for more decentralized clinical trials.

And Canada is prepared to do just that, revealing in a summary on Wednesday in its proposal to modernize its clinical trial system that enabling more of these decentralized trials — centered on patients rather than a single or multiple trial sites — “is an important initiative, as over 30% of the population lives outside medium-sized and large urban areas.”